Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases

Author(s)
Andreas Wasilewicz, Benjamin Kirchweger, Denisa Bojkova, Marie Jose Abi Saad, Julia Langeder, Matthias Butikofer, Sigrid Adelsberger, Ulrike Grienke, Jindrich Cinatl Jr, Olivier Petermann, Leonardo Scapozza, Julien Orts, Johannes Kirchmair, Holger F. Rabenau, Judith M. Rollinger
Abstract

In this study, an integrated in silico-in vitro approach was employed to discover natural products (NPs) active against SARS-CoV-2. The two SARS-CoV-2 viral proteases, i.e., main protease (M

pro) and papain-like protease (PL

pro), were selected as targets for the in silico study. Virtual hits were obtained by docking more than 140,000 NPs and NP derivatives available in-house and from commercial sources, and 38 virtual hits were experimentally validated in vitro using two enzyme-based assays. Five inhibited the enzyme activity of SARS-CoV-2 M

pro by more than 60% at a concentration of 20 μM, and four of them with high potency (IC

50 < 10 μM). These hit compounds were further evaluated for their antiviral activity against SARS-CoV-2 in Calu-3 cells. The results from the cell-based assay revealed three mulberry Diels-Alder-type adducts (MDAAs) from Morus alba with pronounced anti-SARS-CoV-2 activities. Sanggenons C (12), O (13), and G (15) showed IC

50 values of 4.6, 8.0, and 7.6 μM and selectivity index values of 5.1, 3.1 and 6.5, respectively. The docking poses of MDAAs in SARS-CoV-2 M

pro proposed a butterfly-shaped binding conformation, which was supported by the results of saturation transfer difference NMR experiments and competitive

1H relaxation dispersion NMR spectroscopy.

Organisation(s)
Department of Pharmaceutical Sciences
External organisation(s)
Eidgenössische Technische Hochschule Zürich, Geneva University Hospital, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main
Journal
Journal of Natural Products
Volume
86
Pages
264-275
No. of pages
12
ISSN
0163-3864
DOI
https://doi.org/10.1021/acs.jnatprod.2c00843
Publication date
01-2023
Peer reviewed
Yes
Austrian Fields of Science 2012
102004 Bioinformatics, 301207 Pharmaceutical chemistry, 301204 Pharmacognosy
Keywords
ASJC Scopus subject areas
Drug Discovery, Analytical Chemistry, Molecular Medicine, Complementary and alternative medicine, Pharmacology, Pharmaceutical Science, Organic Chemistry
Portal url
https://ucris.univie.ac.at/portal/en/publications/identification-of-natural-products-inhibiting-sarscov2-by-targeting-viral-proteases(607dcfea-8562-4d3f-bf10-5b95e1d4e6b4).html